View by Specialty

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

Emerging Diseases News

SPONSORED CONTENT
Save
SPONSORED CONTENT
July 12, 2024
1 min read
Save

Socioeconomic disparities may increase rate of antimicrobial-resistant organisms

Socioeconomic disparities may increase rate of antimicrobial-resistant organisms

Socioeconomic disparities among residential neighborhoods may be associated with the prevalence of five specific antimicrobial-resistant organisms, especially AmpC beta-lactamase producers and methicillin resistant Staphylococcus aureus.

SPONSORED CONTENT
July 12, 2024
2 min read
Save

Pandemic caused $7B in lost revenue from US electrophysiology procedures in 2020

Pandemic caused $7B in lost revenue from US electrophysiology procedures in 2020

In the United States, the COVID-19 pandemic was associated with more than 50,000 lost electrophysiology procedures totaling more than $7 billion in revenue in 2020, researchers reported in HeartRhythm.

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

SPONSORED CONTENT
July 11, 2024
3 min read
Save

NIH-sponsored trial of nasal COVID-19 vaccine begins enrollment

NIH-sponsored trial of nasal COVID-19 vaccine begins enrollment

A first-in-human trial of a nasal COVID-19 vaccine candidate began enrolling adults aged 18 to 64 years who have received at least three prior doses of a COVID-19 messenger RNA vaccine, according to the NIH.

SPONSORED CONTENT
July 11, 2024
2 min read
Save

Antioxidant therapies for COVID-19 show mixed results

Antioxidant therapies for COVID-19 show mixed results

CHICAGO — Antioxidant therapies showed varying levels of effectiveness when used as a treatment for COVID-19, according to results of a recent systematic review and meta-analysis presented at NUTRITION.

SPONSORED CONTENT
July 09, 2024
2 min read
Save

Paxlovid, though safe, shows no benefit in long COVID treatment

Paxlovid, though safe, shows no benefit in long COVID treatment

A 15-day course of Paxlovid demonstrated no significant benefit for patients with post-acute sequelae of SARS-CoV-2 infection, according to data published in JAMA Internal Medicine.

SPONSORED CONTENT
July 09, 2024
2 min read
Save

Facility doubles infection prevention staff, decreases hospital-related infections

Facility doubles infection prevention staff, decreases hospital-related infections

A Florida hospital doubled the size of its infection prevention staff over a 4-year period and saw a substantial decrease in hospital-related infections, researchers reported at the Association for Professionals in Infection Control and Epidemiology annual meeting.

SPONSORED CONTENT
July 08, 2024
2 min read
Save

Stethoscope disinfection device improves hand hygiene

Stethoscope disinfection device improves hand hygiene

Installation of a stethoscope disinfection device improved hand hygiene compliance among health care workers at an urgent care clinic and ED, researchers reported.

SPONSORED CONTENT
July 05, 2024
5 min read
Save

‘Common and unique immune features’ in long COVID may lead researchers to treatments

‘Common and unique immune features’ in long COVID may lead researchers to treatments

Patients with long COVID symptoms demonstrate elevated levels of several inflammatory molecules — findings that could have important implications in both rheumatology and the search for a potential treatment for long COVID.

SPONSORED CONTENT
July 03, 2024
2 min read
Save

CDC: Fourth US dairy farm worker tests positive for bird flu

CDC: Fourth US dairy farm worker tests positive for bird flu

A dairy farm worker in Colorado became the fourth person to test positive for avian influenza in the ongoing outbreak affecting dairy cows in the United States, the CDC announced Wednesday.

SPONSORED CONTENT
July 02, 2024
2 min read
Save

US gives Moderna $176 million to develop mRNA pandemic flu vaccine

US gives Moderna $176 million to develop mRNA pandemic flu vaccine

HHS announced that it will give Moderna around $176 million to accelerate the development of a messenger RNA-based pandemic influenza vaccine amid an ongoing outbreak of avian influenza.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails